The tert-butyl group is one of the most common aliphatic substituents, appearing in over 50 FDA-approved drugs. Fluorination introduces subtle changes in molecular volume while conferring multiple advantages, such as reduced lipophilicity, improved metabolic stability, and lowered pKa of neighboring functional groups. Since 2023, the groups of O’Hagan and Grygorenko (at Enamine) introduced the β,β,β-trifluoro-tert-butyl moiety, completing the series of mono-/di-/tri-fluoromethyl analogues. Explore our diverse collection of fluoro-tert-butyl compounds to engineer your bioactive molecules!

Concept
We offer
Over 50 tri-/di-/mono-fluoro-tert-butyl compounds from stock on gram scale.
mono-F
di-F
tri-F

